Christine Dos Santos

Christine Dos Santos

Auto-generated profile, based on publicly available information

Christine Dos Santos

INSERM UMR 1169, Bicêtre Gregory Pincus, Le Kremlin Bicêtre, France

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2004 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
CSChristine Dos Santos
Christine Dos Santos
LELaurent Essioux
Laurent Essioux
CTCécile Teinturier
Cécile Teinturier
MTMaïté Tauber
Maïté Tauber
VGVincent Goffin
Vincent Goffin
PBPierre Bougnères
Pierre Bougnères

9 June 2011 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
ALAgnes Linglart
Agnes Linglart
CMChristine Menguy
Christine Menguy
alain couvineaualain couvineau
alain couvineau
CAColette Auzan
Colette Auzan
YGYasemin Gunes
Yasemin Gunes
CSCaroline Silve
Caroline Silve
The skeletal dysplasia characteristic of acrodysostosis resembles the Albright's hereditary osteodystrophy seen in patients with pseudohypoparathyroidism type 1a, but defects in the α-stimulatory subunit of the G-protein (GNAS), the cause of pseudohypoparathyroidism type 1a, are not present in patients with acrodysostosis. We report a germ-line mutation in the gene encoding PRKAR1A, the cyclic AMP (cAMP)–dependent regulatory subunit of protein kinase A, in three unrelated patients with acrodysostosis and resistance to multiple hormones. The mutated subunit impairs the protein kinase A response to stimulation by cAMP; this explains our patients' hormone resistance and the similarities of their skeletal abnormalities with those observed in patients with pseudohypoparathyroidism type 1a.

1 January 2004 in Diabetes
Verified
Journal Article
Closed access
PDF file
SFSophie Le Fur
Sophie Le Fur
CSCatherine Le Stunff
Catherine Le Stunff
CSChristine Dos Santos
Christine Dos Santos
PBPierre BougnèrEs
Pierre BougnèrEs
Uncoupling protein (UCP) 2 is a member of the mitochondrial transporter superfamily that uncouples proton entry in the mitochondrial matrix from ATP synthesis. Although its physiological role remains to be established, UCP2 is considered a candidate gene for association with energy metabolism and obesity. A common promoter polymorphism, −866 G/A, has been associated with increased UCP2 gene expression and middle-aged adult obesity. In fact, our analysis of 296 juvenile obese and 568 nonobese control subjects revealed no difference in the prevalence of this polymorphism. Insulin and glucose response to oral glucose was comparable across the −866 genotypes. Metabolic studies in 147 of these juvenile obese subjects showed that homozygosity for the UCP2 promoter variant A was associated with important changes in energy metabolism compared with other genotypes, i.e., a 34% increase of carbohydrate oxidation (94 ± 10 vs. 70 ± 3 mg · min−1 · m−2, P = 0.004) and a 23% decrease of lipid oxidation (26 ± 3 vs. 34 ± 1 mg · min−1 · m−2, P = 0.03). Therefore, the juvenile obese subjects who are homozygous for the A variant have an increased ratio (3.6 ± 1.2) of calories derived from carbohydrates to those from lipids compared with G/A or G/G obese children (1.4 ± 0.2, P = 0.003), suggesting a role for UCP2 in the partitioning of metabolic fuels.

6 February 2017 in Gene Therapy
Verified
Journal Article
Closed access
PDF file
MPM Perdomini
M Perdomini
CSC Dos Santos
C Dos Santos
CGC Goumeaux
C Goumeaux
VBV Blouin
V Blouin
PBPierre François Bougnères
Pierre François Bougnères

1 February 2009 in Diabetes
Verified
Journal Article
Open access
CSChristine Dos Santos
Christine Dos Santos
PBPierre Bougnères
Pierre Bougnères
DFDelphine Fradin
Delphine Fradin
OBJECTIVE—The G6PC2 gene encoding islet-specific glucose-6-phosphatase related protein (IGRP) has a common promoter variant, rs573225 (−231G/A), located within a Foxa binding site. We tested the cis-regulatory effects of rs573225 on promoter activity and its association with insulin response to oral glucose. RESEARCH DESIGN AND METHODS—Functional effects of rs573225 were explored in transfected INS-1 and HIT-T β-cell lines. A total of 734 young obese subjects of European ancestry were genotyped for rs573225. Insulin and glucose levels were measured in response to oral glucose, and the insulinogenic index (IGI) of insulin secretion was calculated. RESULTS—In vitro, the G allele showed a higher affinity for binding Foxa2 transcription factor and increased G6PC2 promoter activity. Foxa2 binding is modified if the C adjacent to the G allele is methylated. IGI was associated with rs573225 by linear regression analysis and was 30% greater in AA or AG than in GG obese children. rs573225 was also associated with fasting glucose. CONCLUSIONS—rs573225 is a functional cis-regulatory (epi)-single-nucleotide polymorphism (SNP) of G6PC2 associated with glucose-insulin homeostasis in obese children, likely to explain the results of recent genome-wide association studies in nondiabetic adults.

13 February 2004 in Physiological Genomics
Verified
Journal Article
Open access
PDF file
CSChristine Dos Santos
Christine Dos Santos
DFDaniele Fallin
Daniele Fallin
CSCatherine Le Stunff
Catherine Le Stunff
SLSophie LeFur
Sophie LeFur
PBPierre Bougnères
Pierre Bougnères
Dos Santos, Christine, Daniele Fallin, Catherine Le Stunff, Sophie LeFur, and Pierre Bougnères. INS VNTR is a QTL for the insulin response to oral glucose in obese children. Physiol Genomics 16: 309-313, 2004. First published December 2, 2003; 10.1152/ physiolgenomics.00024.2003.— We performed a genotype-phenotype association study to examine whether the insulin VNTR ( INS VNTR) polymorphism located in the insulin gene promoter was associated with changes in insulin response to oral glucose. Two classes of INS VNTR alleles are observed in Caucasians, the “short” class I and the “long” class III. Plasma insulin and glucose concentrations and indices of insulin secretion (IGI) and sensitivity (ISI) were measured using an oral glucose tolerance test (OGTT) in 387 obese children aged 12 ± 0.1 yr with a mean body mass index (BMI) of 30.6 kg/m2 (161% of the normal mean). During OGTT, plasma insulin and IGI were 20–30% higher in I/I obese children vs. III carriers ( P < 0.01). A general linear model adjusting for age, sex, and puberty was also used to evaluate the influence of the VNTR genotype on the BMI-IGI ( P = 0.07) and the BMI-ISI ( P < 0.006) relationships. The INS VNTR can therefore be considered a quantitative trait locus influencing glucose-stimulated insulin physiology in obese juveniles.